|
Please note that this filing was generated from a paper submission to the Securities and Exchange Commission and was not filed electronically. |
<SUBMISSION> <PAPER> <ACCESSION-NUMBER>9999999997-08-024810 <TYPE>ARS <PUBLIC-DOCUMENT-COUNT>1 <PERIOD>20071231 <FILING-DATE>20080508 <DATE-OF-FILING-DATE-CHANGE>20080520 <EFFECTIVENESS-DATE>20080508 <FILER> <COMPANY-DATA> <CONFORMED-NAME>Chelsea Therapeutics International, Ltd. <CIK>0001333763 <ASSIGNED-SIC>2836 <IRS-NUMBER>203174202 <STATE-OF-INCORPORATION>DE <FISCAL-YEAR-END>1231 </COMPANY-DATA> <FILING-VALUES> <FORM-TYPE>ARS <ACT>34 <FILE-NUMBER>000-51462 <FILM-NUMBER>08049403 </FILING-VALUES> <BUSINESS-ADDRESS> <STREET1>13950 BALLANTYNE CORPORATE PLACE <STREET2>UNIT 325 <CITY>CHARLOTTE <STATE>NC <ZIP>28277 <PHONE>704-341-1516 </BUSINESS-ADDRESS> <MAIL-ADDRESS> <STREET1>13950 BALLANTYNE CORPORATE PLACE <STREET2>UNIT 325 <CITY>CHARLOTTE <STATE>NC <ZIP>28277 </MAIL-ADDRESS> </FILER> <DOCUMENT> <TYPE>ARS <SEQUENCE>1 <FILENAME>9999999997-08-024810.paper <DESCRIPTION>AUTO-GENERATED PAPER DOCUMENT <TEXT> This document was generated as part of a paper submission. Please reference the Document Control Number 08049403 for access to the original document. </TEXT> </DOCUMENT> </SUBMISSION> |